Meijun Z. Lundberg

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

Inga‐Marie Schaefer, Meijun Z. Lundberg, Elizabeth G. Demicco et al. · Cancer · 2021 · 35 citations · Full text

Medicine, Oncology, Pathology +17

YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways

Wen‐Bin Ou, Meijun Z. Lundberg, Shuihao Zhu et al. · Oncogenesis · 2021 · 35 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST

Inga‐Marie Schaefer, Matthew L. Hemming, Meijun Z. Lundberg et al. · British Journal of Cancer · 2022 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +11

KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz et al. · Journal of Clinical Oncology · 2024 · 23 citations · Full text

Medicine, Molecular Biology, Oncology +16

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma

Adrián Mariño‐Enríquez, Jan Novotný, D. Gulhan et al. · Clinical Cancer Research · 2023 · 12 citations · Full text

Life Sciences, Oncology, Pharmacology +17